收藏切换
Medication regularity and mechanisms of traditional Chinese medicine in treatment of peritoneal dialysis-associated peritonitis based on data mining and network pharmacology
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(21) : 7883 - 7895
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(21): 7883-7895
Medication regularity and mechanisms of traditional Chinese medicine in treatment of peritoneal dialysis-associated peritonitis based on data mining and network pharmacology
Full
ZHANG Yizhan1, XU Rongjia1, JIANG Chen1
Affiliations
    1 First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine and Acupuncture, Tianjin 300381, China
doi: 10.7501/j.issn.0253-2670.2025.21.019
Outline
收藏切换
Objective To investigate the formulation patterns of traditional Chinese medicine (TCM) in treating peritoneal dialysis-associated peritonitis (PDAP) and explore the mechanism of action of core drug combinations. Methods Clinical records from PDAP patients hospitalized in the Nephrology Department of First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (January 2013—December 2024) were collected to establish a syndrome-pattern and prescription database. Active components were retrieved from Traditional Chinese Medicine Systems Pharmacology Database (TCMSP), HERB, ETCM, and BATMAN-TCM databases, with target prediction via Swiss Target Prediction. Disease-related targets were identified through Digsee, DrugBank, GeneCard, OMIM and NCBI Gene databases. Intersection targets were obtained using the Weishengxin Bioinformatics Platform. Cytoscape was used to construct “active component-intersection target” networks and protein-protein interaction (PPI) networks, with subsequent screening of key components and core targets. Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were performed through DAVID database. Molecular docking was conducted using AutoDock Vina. Results The study included 109 patients with 109 prescriptions, involving two single syndrome patterns and 22 compound patterns, comprising 210 herbs. Herbs predominantly exhibited warm, neutral, cold, and slightly cold properties; sweet, bitter, and pungent flavors; and tropism towards spleen, stomach, liver, and lung meridians. Seven clusters were identified through systematic clustering analysis. The core combination “Banxia (Pinelliae Rhizoma)-Chenpi (Citri Reticulatae Pericarpium)-Sharen (Amomi Fructus)-Zhike (Aurantii Fructus)” contained 94 active components and 1 494 targets, with 561 PDAP-related intersection targets. Key components included quercetin, naringenin, 5,7,8,3',4'-pentamethoxyflavone, carotene, norcotine and skullcapflavone I. Core targets included interleukin-6 (IL6), tumor necrosis factor (TNF), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), albumin(ALB), serine/threonine kinase 1 (AKT1), and interleukin-1 beta (IL1B). KEGG analysis revealed that the main pathways involved were advanced glycation end products-receptor for advanced glycation end products (AGE-RAGE), phosphatidylinositol-3-hydroxykinase (PI3K)-protein kinase B (Akt), hypoxia-inducible factor-1(HIF-1), focal adhesion, and other signaling pathways. Molecular docking demonstrated strong binding affinity between key targets and core components. Conclusion TCM treatment of PDAP primarily focuses on tonifying and protecting the spleen and kidney, resolving dampness, detoxification, regulating qi, and promoting bowel movement, complemented by blood activation and stasis removal.The potential therapeutic targets of the core herbs combination “Pinelliae Rhizoma-Citri Reticulatae Pericarpium-Amomi Fructus-Aurantii Fructus” in the treatment of PDAP primarily involve IL6, TNF, GAPDH, ALB, AKT1, IL1B, etc. Its mechanism of action primarily involves biological processes such as inflammatory responses, negative regulation of apoptotic process and positive regulation of cell population proliferation,which may provide the theoretical basis for TCM in the treatment of PDAP, and the direction for further study of the potential mechanism.
traditional Chinese medicine  /  peritoneal dialysis-associated peritonitis  /  medication regularity  /  Pinelliae Rhizoma-Citri Reticulatae Pericarpium-Amomi Fructus-Aurantii Fructus  /  quercetin  /  naringenin  /  5,7,8,3',4'-pentamethoxyflavone  /  carotene  /  norcotine  /  skullcapflavone I
张艺展, 徐荣佳, 姜晨. 基于数据挖掘和网络药理学探究中医药治疗腹膜透析相关性腹膜炎的用药规律及作用机制. 中草药, 2025 , 56 (21) : 7883 -7895 . DOI: 10.7501/j.issn.0253-2670.2025.21.019
ZHANG Yizhan, XU Rongjia, JIANG Chen. Medication regularity and mechanisms of traditional Chinese medicine in treatment of peritoneal dialysis-associated peritonitis based on data mining and network pharmacology[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (21) : 7883 -7895 . DOI: 10.7501/j.issn.0253-2670.2025.21.019
Year 2025 volume 56 Issue 21
54
13
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.21.019
  • Receive Date:2025-04-26
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2025-04-26
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.21.019
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT